Effects of supplementing with Saccharomyces boulardii on vonoprazan–amoxicillin dual therapy for naive Helicobacter pylori infection: a randomized controlled trial

Abstract Background and aims This randomized controlled trial (RCT) sought to investigate whether Saccharomyces boulardii (S. boulardii) can improve the Helicobacter pylori (H. pylori) eradication rate and reduce adverse events when added to the vonoprazan–amoxicillin dual therapy—a first-line treat...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Zexuan Ji, Dingni Qu, Yonghao Feng, Xiangrong Qin, Xiaoyong Wang
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	BMC 2026-04-01
Цуврал:	BMC Gastroenterology
Нөхцлүүд:	Helicobacter pylori Saccharomyces boulardii Vonoprazan Dual therapy Randomized controlled trial
Онлайн хандалт:	https://doi.org/10.1186/s12876-026-04865-8
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!